Article
Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.
Atherosclerosis - 1 Aug 2015
Pokharel Yashashwi, Sun Wensheng, Polfus Linda M, Folsom Aaron R, Heiss Gerardo, Sharrett A Richey, Boerwinkle Eric, Ballantyne Christie M, Hoogeveen Ron C
Abstract excerpt
OBJECTIVE: Lipoprotein-associated phospholipase A2 (LpPLA2) activity was associated with higher CHD risk in a meta-analysis, which was partly dependent on circulating lipid levels. Apolipoprotein C3 loss-of-function (ApoC3 LOF) mutations were related with reduced postprandial lipemia and CHD risk. However, the association of LpPLA2 activity with ApoC3 LOF is not known. METHODS: We examined the association of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
